Quadcap Wealth Management’s Annovis Bio ANVS Stock Holding History

Quadcap Wealth Management’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30K	Buy	+16,110	New	+$31.3K	﹤0.01%	426

Other funds holding ANVS

First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return

Sherry Group Mountain Home, Arkansas $102M AUM

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Quadcap Wealth Management's ANVS Position: Q2 2026 in Review

Quadcap Wealth Management opened a new position in Annovis Bio (ANVS) in Q2 2026: 16,110 shares worth $30K. The stake represents ﹤0.01% of the portfolio and ranks #426 among its holdings.

13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Quadcap Wealth Management held 16,110 shares of Annovis Bio worth $30K as of Q2 2026.
Annovis Bio was a new Quadcap Wealth Management position in Q2 2026.
Annovis Bio made up ﹤0.01% of Quadcap Wealth Management's portfolio in Q2 2026, its #426 holding.
13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Quadcap Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.